TECH Operating cash flow
Operating cash flow at Bio-Techne fell to $288M in fiscal 2025, from $299M in 2024.
Net cash provided by operating activities, as filed.
SOURCE: us-gaap:NetCashProvidedByUsedInOperatingActivities · EDGAR CompanyFacts · CIK 842023 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
FY2025$288M
FY2024 $299M
HIGH$352M FY2021
LOW$254M FY2023
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Operating cash flow | Change |
|---|---|---|
| FY2025 | $288M | $-11M |
| FY2024 | $299M | +$45M |
| FY2023 | $254M | $-71M |
| FY2022 | $325M | $-27M |
| FY2021 | $352M | — |
More SAME DATA, OTHER VIEWS
Operating cash flow across coverage → · TECH company view →
Revenue · Net income · Free cash flow · Capital expenditure · Cash & equivalents · Total assets · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.